BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 31557977)

  • 1. Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression.
    Jolly MK; Celià-Terrassa T
    J Clin Med; 2019 Sep; 8(10):. PubMed ID: 31557977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?
    Jolly MK; Tripathi SC; Somarelli JA; Hanash SM; Levine H
    Mol Oncol; 2017 Jul; 11(7):739-754. PubMed ID: 28548388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical Modeling of Plasticity and Heterogeneity in EMT.
    Tripathi S; Xing J; Levine H; Jolly MK
    Methods Mol Biol; 2021; 2179():385-413. PubMed ID: 32939734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic neuroblastoma cancer stem cells exhibit flexible plasticity and adaptive stemness signaling.
    Pandian V; Ramraj S; Khan FH; Azim T; Aravindan N
    Stem Cell Res Ther; 2015 Feb; 6(1):2. PubMed ID: 25888913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Plasticity and Prostate Cancer: The Role of Epithelial-Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance.
    Papanikolaou S; Vourda A; Syggelos S; Gyftopoulos K
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stochastic population dynamics of cancer stemness and adaptive response to therapies.
    Jain P; Duddu AS; Jolly MK
    Essays Biochem; 2022 Sep; 66(4):387-398. PubMed ID: 36073715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.
    Neelakantan D; Drasin DJ; Ford HL
    Cell Adh Migr; 2015; 9(4):265-76. PubMed ID: 25482627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communication Between Epithelial-Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression.
    Zheng X; Dai F; Feng L; Zou H; Feng L; Xu M
    Front Oncol; 2021; 11():617597. PubMed ID: 33968721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity.
    Vernot JP
    Front Mol Biosci; 2020; 7():63. PubMed ID: 32478091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-to-Mesenchymal Plasticity Harnesses Endocytic Circuitries.
    Corallino S; Malabarba MG; Zobel M; Di Fiore PP; Scita G
    Front Oncol; 2015; 5():45. PubMed ID: 25767773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Stemness and EMT Based Gene Expression Signature Identifies Phenotypic Plasticity and is A Predictive but Not Prognostic Biomarker for Breast Cancer.
    Akbar MW; Isbilen M; Belder N; Canli SD; Kucukkaraduman B; Turk C; Sahin O; Gure AO
    J Cancer; 2020; 11(4):949-961. PubMed ID: 31949498
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance.
    Gupta PB; Pastushenko I; Skibinski A; Blanpain C; Kuperwasser C
    Cell Stem Cell; 2019 Jan; 24(1):65-78. PubMed ID: 30554963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell Heterogeneity and Phenotypic Plasticity in Metastasis Formation: The Case of Colon Cancer.
    Teeuwssen M; Fodde R
    Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamical hallmarks of cancer: Phenotypic switching in melanoma and epithelial-mesenchymal plasticity.
    Jain P; Pillai M; Duddu AS; Somarelli JA; Goyal Y; Jolly MK
    Semin Cancer Biol; 2023 Nov; 96():48-63. PubMed ID: 37788736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-to-mesenchymal transition in tumor progression.
    Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
    Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness.
    Karagiorgou Z; Fountas PN; Manou D; Knutsen E; Theocharis AD
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response.
    Jia D; Li X; Bocci F; Tripathi S; Deng Y; Jolly MK; Onuchic JN; Levine H
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31121840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis.
    Wang Y; Dong C; Zhou BP
    Genes Dis; 2020 Jun; 7(2):172-184. PubMed ID: 32215287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
    Jayachandran A; Dhungel B; Steel JC
    J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.